SMTL ID : 3uuo.2 (1 other biounit)

The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.11 Å

Oligo State

monomer

Ligands

1 x 0CV: 6-methoxy-3,8-dimethyl-4-(piperazin-1-yl)-1H-pyrazolo[3,4-b]quinoline(Non-covalent)

0CV.1: 15 residues within 4Å: Chain A: Y.91, H.92, L.202, L.242, S.244, V.245, I.259, Y.260, F.263, M.280, G.292, Q.293, F.296, Y.297 Ligands: PO4.4 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:F.296 Hydrogen bonds: A:Q.293, A:Q.293 pi-Stacking: A:F.263, A:F.296, A:F.296

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 6 residues within 4Å: Chain A: H.130, D.131, H.134, H.162 Ligands: ZN.3, PO4.4 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:D.131, H2O.1, H2O.1, H2O.2, H2O.2

1 x ZN: ZINC ION(Non-covalent)

ZN.3: 8 residues within 4Å: Chain A: H.92, H.96, V.100, H.130, D.131, D.241 Ligands: MG.2, PO4.4 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.96, A:H.130, A:D.131, A:D.241, H2O.2

1 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.4: 10 residues within 4Å: Chain A: Y.91, H.92, H.96, D.131, H.134, T.200, D.241 Ligands: 0CV.1, MG.2, ZN.3 6 PLIP interactions: 6 interactions with chain A Water bridges: A:H.134, A:H.134, A:E.159, A:E.159, A:T.200 Salt bridges: A:H.92

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ho, G.D. et al., The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-01-25

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence